Medical Research Program
- Workshop Date / Location: January 21-23, 2025 / Miami, FL
- Letter of Intent Deadline: Applications are now closed.
- Letter of Intent Notification Date: September 30, 2024
- Workshop Participation Grant Amount: $10,000 / invited participant
- Post-workshop Research Grant Amount: $500,000 direct costs over 2 years. No indirect costs allowed.
- Post-workshop Grant Notification Date: July 15, 2025
- Start of Post-workshop Grant Term: Fourth quarter 2025
Overview
The Rainwater Charitable Foundation (RCF), along with our partners CurePSP, Alzheimer’s Association, and the Aging Mind Foundation, is pleased to announce the second Tauopathy Challenge WorkshopTM that will focus on addressing key gaps in our understanding of copathologies that are often present with the primary tauopathies.
The presence of copathologies can complicate diagnosis and therapeutic development for the primary tauopathies. There is a need for the research field to understand how aggregate-forming proteins like tau propagate in the brain, and how those pathological species derive from, instigate the formation of, or interact with other pathologies.
Please note that LOIs solely studying the role of amyloid beta (Aβ) and tau interaction will not be considered.
Process
Workshop participants will be selected through a competitive Letter of Intent (LOI) process. Through the LOI process, up to 12 participants will be selected by the RCF to attend the workshop and each attendee will receive a $10,000 grant to support their laboratory research. Travel and lodging expenses will also be covered.
Following the meeting, workshop attendees can apply for research grants providing up to $500,000 over two years; up to four awards will be funded, pending budget availability.
Letters of Intent
The LOI will be used to identify novel ideas from researchers with diverse insights to solve key gaps in our understanding of the mechanisms of copathology with a focus on primary tauopathies (i.e., Pick’s disease, progressive supranuclear palsy, corticobasal degeneration, argyrophilic grain disease, globular glial tauopathy, aging-related tau astrogliopathy, and frontotemporal dementias). Applications from researchers with expertise in other neurodegenerative diseases are strongly encouraged to apply.
LOI applications are now closed. Applicants will be notified by September 30, 2024.
Funding Partners
